GlassScriptPhysician profile
David N Garras
NPI 1386847283
$658,409.43
in general payments reported to CMS, 2019-2025
37 companies · $64K in 2025
The $64K reported for 2025 was more than what 92% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $13K · 2021: $130K · 2022: $45K · 2023: $289K · 2024: $53K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $246K · Royalty Or License: $116K · Consulting Fee: $29K · Food and Beverage: $7,283 · Education: $4,000 · Travel and Lodging: $3,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $245,998.89 |
| Royalty Or License | $116,182.08 |
| Consulting Fee | $29,024.64 |
| Food and Beverage | $7,283.25 |
| Education | $4,000.00 |
| Travel and Lodging | $3,299.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $246,584.13 | 2023-2024 | Magellan |
| Flower Orthopedics Coporation | $117,939.39 | 2020-2025 | Fibula Nail, 3.5mm X 180mm, Titanium, Flex-Thread, Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread, Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread |
| Medshape, INC. | $96,851.48 | 2019-2024 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Extremity Medical | $94,635.92 | 2019-2025 | Omni, Io Fix |
| Stryker Corporation | $33,347.26 | 2019-2025 | Variax, Augment Injectable, Infinity |
| Amniox Medical, INC. | $29,103.88 | 2019 | |
| Arthrex, INC. | $8,144.78 | 2019-2021 | |
| Conventus Orthopaedics, INC. | $8,037.50 | 2019-2020 | |
| Biotissue Holdings INC. | $5,718.13 | 2019-2022 | |
| Pathway Medical Partners, LLC | $4,000.00 | 2024 | |
| Ortho Solutions INC | $3,420.43 | 2019-2025 | |
| Crossroads Extremity Systems, LLC | $2,864.00 | 2019-2021 | |
| Depuy Synthes Sales INC. | $2,698.67 | 2022-2025 | Na, Motoband, Fibergraft Aeridyan Matrix |
| Medwest Associates | $1,025.52 | 2020-2022 | |
| Microaire Surgical Instruments LLC | $800.00 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirus, LLC | $740.22 | 2023 | Atlas Plating System |
| Wright Medical Technology, INC. | $599.65 | 2019-2020 | |
| International Life Sciences | $500.00 | 2020 | |
| Fusion Orthopedics USA, LLC | $373.48 | 2023-2024 | |
| Linvatec Corporation | $146.05 | 2024 | Biobrace 23mm |
| Novastep INC. | $145.92 | 2021 | |
| Surgenex LLC | $141.20 | 2025 | Pellograft, Renograft, Surgraft |
| Anika Therapeutics, INC. | $130.48 | 2024 | X-Twist |
| Treace Medical Concepts, INC. | $103.18 | 2023 | |
| Paragon 28, INC. | $69.30 | 2021-2022 | |
| Lightbody Medical Technologies INC | $42.61 | 2024-2025 | |
| Globus Medical, INC. | $42.43 | 2023 | Evo Retrograde |
| Smith+Nephew, INC. | $40.02 | 2022 | |
| Fusion Orthopedics, LLC. | $38.07 | 2019 | |
| Abbott Laboratories | $27.37 | 2025 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $22.92 | 2025 | |
| Bone Support INC. | $15.95 | 2024 | Cerament G, Ceramentbone Void Filler |
| Pacira Therapeutics, INC. | $14.93 | 2019 | |
| Djo, LLC | $14.34 | 2025 | Cmf |
| Sanofi-Aventis U.S. LLC | $12.96 | 2023 | |
| Kerecis Limited | $8.83 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $8.43 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$136,845.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Garras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.